Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design

Lignende værker

• Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
  af: Koon, Henry B, et al.
  Udgivet: (2010)
• PHASE II AIDS MALIGNANCY CONSORTIUM TRIAL OF TOPICAL HALOFUGINONE IN AIDS-RELATED KAPOSI’S SARCOMA
  af: Koon, Henry B., et al.
  Udgivet: (2011)
• Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042
  af: Koon, Henry B., et al.
  Udgivet: (2014)
• Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study
  af: Krown, Susan E., et al.
  Udgivet: (2012)
• AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma
  af: Reid, Erin G., et al.
  Udgivet: (2019)